Conditions

LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS

Drug approval information sourced from the FDA and the PBS. Updated nightly from public government registries. Not medical advice.

Access in Australia

  • The active ingredients of this medicine are listed on the PBS, though not together as this exact product, according to the Pharmaceutical Benefits Scheme. Your doctor can advise which PBS-subsidised options are available.
  • TGA registration data for this medicine is not yet available on Voxsanity.
Updated regularly from public government registries

How it works: Angiotensin-converting Enzyme Inhibitors

Drug class: ACE inhibitors, plain

Approval status

FDA Approved

1 July 2002
US Food and Drug Administration

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Regulatory approval does not guarantee this drug is available to you. Availability in Australia depends on PBS listing status, your specific diagnosis, your doctor's assessment, and other clinical factors.

Accessing this drug in Australia

The active ingredients of this medicine are listed on the PBS, though not together as this exact product. Your doctor can advise which PBS-subsidised options are available.

This information is drawn from publicly available PBS records. It is not medical advice. Consult your doctor about access options for your specific situation.

Approval data sourced from openFDA (CC0 licence), and the PBS schedule. Updated nightly. This page does not constitute medical advice. Drug availability and PBS listing status may change. Verify current availability and PBS coverage with your doctor or pharmacist.